Cyclin E1 is a prognostic biomarker and potential therapeutic target in osteosarcoma
Ran Wei(University of California, Los Angeles), Zhenfeng Duan(Harvard University)
Cited by 30
Related Papers
Targeting Cdk11 in osteosarcoma cells using the CRISPR‐cas9 system
|Journal of Orthopaedic Research®|2014|106
Targeting <i>ABCB1 (MDR1)</i> in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance
|Oncotarget|2016|88
The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer
|Oncotarget|2016|74
SD-1029 Inhibits Signal Transducer and Activator of Transcription 3 Nuclear Translocation
|Clinical Cancer Research|2006|67
Expression and clinical implications of leucine‐rich repeat containing 15 (LRRC15) in osteosarcoma
|Journal of Orthopaedic Research®|2020|29